{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:53Z","timestamp":1792176053999,"version":"4.4.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":9,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study was performed to identify risk factors associated with recurrence of hepatoblastoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective study was conducted on 56 patients with hepatoblastoma from 2012 to 2015 in Beijing Children\u2019s Hospital. Pretreatment extension stage (PRETEXT), serum alpha fetoprotein (AFP) value, change trend of tumors after treatment and some other clinical characteristics were collected and analyzed. The comparison of independent variables that were not distributed normally was performed with the log-rank test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twenty-eight patients with tumour recurrence and 28 patients without recurrence were included in this study, and the median age at presentation was 46.5 (26, 71.5) months. There was a significant difference in the 3-year recurrence-free survival (RFS) probability between patients aged over 54\u2009months and those younger than 54\u2009months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). After neoadjuvant chemotherapy, the chance of recurrence in partial response (PR) patients was significantly lower than that in stable disease (SD) patients (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.004). The 3-year RFS rate of patients with a reduction in AFP of more than 60% after neoadjuvant chemotherapy was significantly higher than that of patients with a reduction of less than 60% (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.005). The postoperative follow-up revealed that patients whose postoperative AFP fell to normal levels within 6\u2009months of the start of treatment had a 3-year RFS rate of 68.6%, which is higher than that of patients whose AFP fell below the normal range after 6\u2009months (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0005). Finally, the multivariate analysis by Cox regression showed that AFP decreased by less than 60% and tumour size decreased by less than 50% after neoadjuvant chemotherapy were significant independent prognostic risk factors for the 3-year RFS rate. The other clinical features were not significantly associated with tumour recurrence in this study.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Through this study, we concluded that the prognosis of childhood HB is related to the age at presentation and the response of chemotherapy. The results of the multivariate analysis showed that AFP decreased by less than 60% and tumour size decreased by less than 50% after neoadjuvant chemotherapy were significant independent prognostic risk factors. These findings can be helpful to evaluate therapeutic effects and predict prognosis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-019-1870-3","type":"journal-article","created":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T03:02:59Z","timestamp":1575946979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Analysis of factors related to recurrence of paediatric hepatoblastoma - a single Centre retrospective study"],"prefix":"10.1186","volume":"19","author":[{"given":"Wei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8338-0325","authenticated-orcid":false,"given":"Huanmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,10]]},"reference":[{"key":"1870_CR1","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1002\/pbc.25128","volume":"11","author":"LM Turcotte","year":"2014","unstructured":"Turcotte LM, Georgieff MK, Ross JA, et al. Neonatal medical exposures and characteristics of low birth weight hepatoblastoma cases: a report from the Children's oncology group. Pediatr Blood Cancer. 2014;11:2018\u201323.","journal-title":"Pediatr Blood Cancer"},{"key":"1870_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/MPH.0000000000001097","volume":"41","author":"J Bennett","year":"2019","unstructured":"Bennett J, Kirby-Allen M, Ng V, et al. Hepatoblastoma in a child with early-onset cirrhosis. J Pediatr Hematol Oncol. 2019;41:30\u20133.","journal-title":"J Pediatr Hematol Oncol"},{"key":"1870_CR3","unstructured":"Meyers RL, Aronson DC, von Schweinitz D, et al. Pediatric liver tumors, in Pizzo PA, Poplack DG (eds): principles and practice in pediatric oncology. Philadelphia, PA, Wolters Kluwer, Lippincott. Williams Wilkins, 2011, 838\u201360."},{"key":"1870_CR4","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1067\/S0022-3476(03)00306-8","volume":"2","author":"CL Clericuzio","year":"2003","unstructured":"Clericuzio CL, Chen E, McNeil DE, et al. Serum alpha-fetoprotein screening for hepatoblastoma in children with Beckwith-Wiedemann syndrome or isolated hemihyperplasia. J Pediatr. 2003;2:270\u20132.","journal-title":"J Pediatr"},{"key":"1870_CR5","doi-asserted-by":"crossref","unstructured":"De Ioris M, Brugieres L, Zimmermann A, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Europen J Cancer. 2008;2008(44):545\u201350.","DOI":"10.1016\/j.ejca.2007.11.022"},{"key":"1870_CR6","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/bjs.9681","volume":"102","author":"R Venkatramani","year":"2015","unstructured":"Venkatramani R, Stein JE, Sapra A, et al. Effect of neoadjuvant chemotherapy on resectability of stage III and IV hepatoblastoma. Br J Surg. 2015;102:108\u201313.","journal-title":"Br J Surg"},{"key":"1870_CR7","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1053\/j.sempedsurg.2016.09.002","volume":"5","author":"DC Aronson","year":"2016","unstructured":"Aronson DC, Meyers RL. Malignant tumors of the liver in children. Semin Pediatr Surg. 2016;5:265\u201375.","journal-title":"Semin Pediatr Surg"},{"key":"1870_CR8","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/lt.24847","volume":"12","author":"R Vinayak","year":"2017","unstructured":"Vinayak R, Cruz RJ Jr, Ranganathan S, et al. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015). Liver Transpl. 2017;12:1577\u201388.","journal-title":"Liver Transpl"},{"key":"1870_CR9","first-page":"29","volume":"26","author":"RL Meyers","year":"2014","unstructured":"Meyers RL, Tiao G, jv G, et al. Hepatoblastoma state of the art: pre-treatment extent of disease, surgical resection guidelines and the role of liver transplantation. Hematol Oncol. 2014;26:29\u201336.","journal-title":"Hematol Oncol"},{"key":"1870_CR10","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1200\/JCO.2010.29.3837","volume":"29","author":"MH Malogolowkin","year":"2011","unstructured":"Malogolowkin MH, Katzenstein HM, Meyers RL, et al. Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's oncology group. J Clin Oncol. 2011;29:3301\u20136.","journal-title":"J Clin Oncol"},{"key":"1870_CR11","first-page":"153","volume":"13","author":"G Perilongo","year":"2011","unstructured":"Perilongo G, Morland B, Malogolowkin M, et al. Chemotherapy for childhood hepatoblastoma and hepatocellular carcinoma. Pediatric liver tumors. Heidelberg. Springer. 2011;13:153\u201364.","journal-title":"Springer"},{"key":"1870_CR12","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jpedsurg.2015.10.053","volume":"4","author":"Y Shi","year":"2016","unstructured":"Shi Y, Geller JI, Ma IT, et al. Relapsed hepatoblastoma confined to the lung is effectively treated with pulmonary metastasectomy. J Pediatr Surg. 2016;4:525\u20139.","journal-title":"J Pediatr Surg"},{"key":"1870_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","volume":"9","author":"J Zsiros","year":"2013","unstructured":"Zsiros J, Brugieres L, Brock P, et al. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study. Lancet Oncol. 2013;9:834\u201342.","journal-title":"Lancet Oncol"},{"issue":"37","key":"1870_CR14","first-page":"123","volume":"2007","author":"DJ Roebuck","year":"2005","unstructured":"Roebuck DJ, Aronson D, Clapuyt P, et al. PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol. 2005;2007(37):123\u201332.","journal-title":"Pediatr Radiol"},{"key":"1870_CR15","unstructured":"WHO. WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland, World Health Orgnaization,1979,205\u2013216."},{"key":"1870_CR16","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/modpathol.2013.80","volume":"3","author":"D L\u00f3pez-Terrada","year":"2014","unstructured":"L\u00f3pez-Terrada D, Alaggio R, de D\u00e1vila MT, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the los Angeles COG liver tumors symposium. Mod Pathol. 2014;3:472\u201391.","journal-title":"Mod Pathol"},{"key":"1870_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-3-642-14504-9_8","volume-title":"Pediatric liver tumors","author":"DJ Roebuck","year":"2011","unstructured":"Roebuck DJ, Perilongo G, Malogolowkin M, et al. Pediatric liver tumors. Heidelberg: Springer; 2011. p. 65\u201382."},{"key":"1870_CR18","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","volume":"52","author":"P Czauderna","year":"2016","unstructured":"Czauderna P, Haeberle B, Hiyama E, et al. The Children\u2019s hepatic tumors international collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model. Eur J Cancer. 2016;52:92\u2013101.","journal-title":"Eur J Cancer"},{"key":"1870_CR19","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1007\/s00383-013-3399-0","volume":"29","author":"E Hiyama","year":"2013","unstructured":"Hiyama E, Ueda Y, Onitake Y, et al. A cisplatin plus pirarubicin-based JPLT2 chemotherapy for hepatoblastoma: experience and future of the Japanese study Group for Pediatric Liver Tumor (JPLT). Pediatr Surg Int. 2013;29:1071\u20135.","journal-title":"Pediatr Surg Int"},{"key":"1870_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00383-010-2708-0","volume":"27","author":"T Hishiki","year":"2011","unstructured":"Hishiki T, Matsunaga T, Sasaki F, et al. Outcome of hepatoblastomas treated using the Japanese study Group for Pediatric Tumor (JPLT) protocol 2: report from the JPLT. Pediatr Surg Int. 2011;27:1\u20138.","journal-title":"Pediatr Surg Int"},{"key":"1870_CR21","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/j.jpedsurg.2016.09.038","volume":"12","author":"E Hiyama","year":"2016","unstructured":"Hiyama E, Hishiki T, Watanabe K, et al. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese study Group for Pediatric Liver Tumor (JPLT)-2 protocol. J Pediatr Surg. 2016;12:2053\u20137.","journal-title":"J Pediatr Surg"},{"key":"1870_CR22","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ejca.2012.10.003","volume":"4","author":"M Semeraro","year":"2013","unstructured":"Semeraro M, Branchereau S, Maibach R, et al. Relapses in hepatoblastoma patients: clinical characteristics and outcome-experience of the international childhood liver tumors strategy group (SIOPEL). Eur J Cancer. 2013;4:915\u201322.","journal-title":"Eur J Cancer"},{"key":"1870_CR23","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/SLA.0000000000001936","volume":"266","author":"Jo \u0308rg Fuchs","year":"2017","unstructured":"Jo \u0308rg Fuchs, Cavdar S, Blumenstock G, et al. POST-TEXT III and IV Hepatoblastoma extended hepatic resection avoids liver transplantation in selected cases. Ann Surg. 2017;266:318\u201323.","journal-title":"Ann Surg"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1870-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1870-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1870-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T20:27:14Z","timestamp":1607459234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1870-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1870"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1870-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.14548\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.14548\/v2","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"1 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The current study was approved by the Committee on Human Study of the Beijing Children\u2019s Hospital and the Ethics Review Committee of Beijing Children\u2019s Hospital (No. 2019-k-11).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All of the authors including Wei Yang, Yiwei Chen, Yijin Huang and Huanmin Wang declare that they had no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"485"}}